PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	15.41	15.17	50.18	68.04	85.4	2.2
Short-Term Investments	5.2	0.37	-	-	-	-
Cash & Short-Term Investments	20.61	15.54	50.18	68.04	85.4	2.2
Cash Growth	-1.12%	-69.03%	-26.25%	-20.33%	3778.14%	146.08%
Other Receivables	-	3.7	-	-	-	-
Receivables	-	3.7	-	-	-	-
Prepaid Expenses	0.5	0.22	0.26	0.11	0.09	0.07
Other Current Assets	1.91	2.92	-	-	-	-
Total Current Assets	23.02	22.38	50.44	68.15	85.49	2.28
Long-Term Investments	20.75	22.47	-	1.57	1.57	1.57
Other Intangible Assets	1.55	1.55	1.55	3.55	3.55	3.55
Other Long-Term Assets	10.66	8.77	7.91	0.01	0.01	0.01
Total Assets	55.98	55.17	59.9	73.28	90.62	7.4
Accounts Payable	1.02	0.4	0.39	0.13	0.21	0.17
Accrued Expenses	0.35	0.52	0.74	0.46	0.5	0.5
Short-Term Debt	-	-	-	-	-	0.05
Other Current Liabilities	0.21	1.99	6.3	-	-	-
Total Current Liabilities	1.58	2.91	7.42	0.59	0.7	0.72
Other Long-Term Liabilities	17.85	0.36	12.97	-	-	-
Total Liabilities	19.42	3.28	20.39	0.59	0.7	0.72
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	180.61	181.49	185.33	202.23	201.58	114.11
Retained Earnings	-100.75	-84.97	-115.63	-115.96	-111.65	-107.41
Treasury Stock	-44.61	-44.61	-42.04	-13.56	-	-
Comprehensive Income & Other	0.39	-0.02	-0.02	-0.02	-0.02	-0.02
Total Common Equity	35.65	51.89	27.65	72.69	89.92	6.68
Shareholders' Equity	36.55	51.89	39.51	72.69	89.92	6.68
Total Liabilities & Equity	55.98	55.17	59.9	73.28	90.62	7.4
Total Debt	-	-	-	-	-	0.05
Net Cash (Debt)	20.61	15.54	50.18	68.04	85.4	2.15
Net Cash Growth	-1.12%	-69.03%	-26.25%	-20.33%	3869.72%	204.54%
Net Cash Per Share	3.01	2.12	5.24	3.49	5.50	1.49
Filing Date Shares Outstanding	10.13	6.8	7.71	8.78	20.75	1.61
Total Common Shares Outstanding	6.8	6.8	8.04	16.79	20.72	1.59
Working Capital	21.44	19.46	43.02	67.56	84.79	1.55
Book Value Per Share	5.25	7.64	3.44	4.33	4.34	4.20
Tangible Book Value	34.1	50.34	26.1	69.14	86.37	3.13
Tangible Book Value Per Share	5.02	7.41	3.25	4.12	4.17	1.97

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q